As drugs progress in HIV, attitudes lag behind

A new survey from Gilead Sciences (Nasdaq: GILD) has indicated that stigma facing people living with HIV (PLHIV) remains widespread despite medical progress.

The study, titled Is HIV Sorted?, included responses from 24,000 participants from 12 European countries and was conducted alongside International Association of Providers of AIDS Care (IAPAC).

Across Europe, 68% of survey respondents would not be comfortable dating PLHIV. That number is higher in Eastern Europe, at 74%, where people are also more likely to object to working alongside PLHIV (52% versus 24% in western Europe).